Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

US Government cuts to mRNA vaccine research could set technological advances, reduce access and raise costs for new therapies, experts have warned.

Other objections to mRNA technology have come from a fundamental misunderstanding of how it works. Claims that mRNA can somehow alter your DNA are often made by vaccine skeptics, but this is ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments for cancers, cystic fibrosis, and rare diseases.

“We’re all feeling it,” the founder of a Vermont mRNA manufacturer said of federal cuts.

They’re turning their backs on a technology thought to have saved millions of lives—with the potential to save many more.

That unprecedented speed, which saved millions of lives, was possible only because years earlier, the United States invested in a vaccine technology called mRNA.

What’s mainly changed since then is that we have only advanced our understanding and technology to keep infectious diseases from running rampant in our society. One such technological leap was ...

Dr. Sarah Boyd, an infectious disease specialist with Saint Luke's Health System, told KCUR that federal cuts to mRNA research and development could cause a setback in pandemic preparedness.